BLOG

New DEA Guidance On Quantitative Thresholds

New DEA Guidance On Quantitative Thresholds

Guidance On Quantitative Thresholds Written-by: Deneen Fumich, RPh As the Pharmaceutical Supply Chain continues to digest the Injunctive Relief requirements for the Big 3 Wholesalers, questions have been posed by industry to both the DEA and State Regulators as to the...

read more
NABP
Optum Rx & NABP DDA Lawsuit Update

Optum Rx & NABP DDA Lawsuit Update

Optum Rx’s requirement for their network pharmacies to only purchase prescription drug and diabetic testing supplies from Accredited wholesalers has caused significant disruption and controversy since its implementation in August 2016. The requirement spurred two separate lawsuits. The second, which continues in full force, has a recent amended complaint – and Pharma Solutions has unique insight into the lawsuit’s developments.

read more

Email Newsletter